Get started Log in

182400 — NKGen Biotech Korea Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro Cap

Brief: Nkmax Wins 1.8 Billion Won Order
21/07/2023 08:10
Brief: NKMax And Merck Expand Clinical Collaboration
13/04/2021 14:33
Brief: ATGen issues 8th tranche convertible bonds worth 27.5 bln won
26/06/2018 10:00
Brief: ATGen to buy stake in NK MAX for 27.47 bln won
22/06/2018 08:22
Brief: ATGen to issue 8th series convertible bonds worth 27.5 bln won
22/06/2018 03:49
Brief: ATGen issues 7th series convertible bonds worth 9 bln won
30/03/2018 12:18
Brief: ATGen signs contract worth 3 bln won
30/01/2018 01:54
Brief: ATGen says conversion of 6th series convertible bonds into shares
21/09/2017 10:33
Brief: ATGen lowers conversion price of 6th series convertible bonds to 30,530 won/share
29/08/2017 16:48
Brief: ATGen signs contract worth 4.05 bln won
08/05/2017 07:13
Brief: ATGen signs contract worth 727.3 mln won
21/03/2017 06:45
Brief: ATGen signs contract worth 327.3 mln won
10/03/2017 03:17
Brief: ATGen signs contract worth 409.1 mln won
06/03/2017 01:34
Brief: ATGen signs contract worth 2.51 bln won
16/02/2017 01:23
Brief: ATGen says Korea Investment Value Asset Management ups stake to 8.6 pct
01/02/2017 08:14
Brief: ATGen signs contract worth 1.65 bln won
16/01/2017 09:31
Brief: Korea Value Asset Management buys 5.0 pct stake in ATGen
28/11/2016 06:17